In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

GSK signs broad collaboration with Theravance

Executive Summary

GlaxoSmithKline PLC and Theravance (developing drugs in several therapeutic areas), partners in the development of respiratory drugs since January 2003, have entered another agreement. Under terms of the new deal, which they are calling "Beyond Advair," GSK gets an exclusive worldwide development and marketing option to any of Theravance's current or future drug candidates through August 2007.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity
    • R+D and Marketing-Licensing
    • Includes Royalty or Profit Split Information
    • Includes Contract

Related Companies

Advertisement
UsernamePublicRestriction

Register